Anorectal Malformations
|
0.020 |
AlteredExpression
|
group |
BEFREE |
Western blot and real time RT-PCR revealed that Wif1 and β-catenin protein and mRNA expression level was significantly decreased in the ARM groups compared with the normal group on GD14 and GD15 (<i>p</i> < 0.05).
|
29507836 |
2018 |
Aortic Valve Stenosis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
Our main findings were: (1) serum levels of all Wnt modulators were markedly elevated in patients with symptomatic AS (mean increase 231% to 278%, P<0.001), (2) all Wnt modulators were present in calcified aortic valves but correlated poorly with systemic levels or degree of AS, (3) some modulators (ie, WIF-1) were associated with the degree of myocardial function and valvular calcification, (4) all Wnt modulators, and DKK-1 in particular, predicted long-term mortality in these patients also after adjusting for conventional predictors including NT-proBNP.
|
23316316 |
2012 |
Arthritis
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
WIF-1 expression was repressed by TNFα in chondrocytes and osteoblasts and down-regulated in experimental arthritis and in articular cartilage from patients with rheumatoid arthritis.
|
23784913 |
2013 |
Astrocytoma
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
Our results suggested that the WIF-1 gene is frequently silenced in astrocytoma by aberrant promoter methylation.
|
20539942 |
2010 |
Astrocytoma
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
The mean percent methylation of the WIF1 promoter in astrocytomas was higher than that in control brain tissue.
|
23328978 |
2013 |
Atrial Premature Complexes
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
After transfection with miR-BART19-3p mimics, the expression of WIF1, and APC decreased, and the cellular proliferation rate increased.
|
28543390 |
2017 |
Bacterial Infections
|
0.010 |
AlteredExpression
|
group |
BEFREE |
Role of bacterial infection in the epigenetic regulation of Wnt antagonist WIF1 by PRC2 protein EZH2.
|
25486432 |
2015 |
Barrett Esophagus
|
0.010 |
Biomarker
|
disease |
LHGDN |
Epigenetic alteration of the Wnt inhibitory factor-1 promoter occurs early in the carcinogenesis of Barrett's esophagus.
|
18005197 |
2008 |
Barrett Esophagus
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
In addition, we found that WIF-1 hypermethylation was more frequent in BE samples from patients with EAC than in BE samples from patients who had not progressed to EAC.
|
18005197 |
2008 |
Bladder Neoplasm
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Nuclear accumulation of beta-catenin was significantly more frequent in bladder tumor than in bladder mucosa and inversely correlated with Wif-1 expression.
|
16428476 |
2006 |
Bladder Neoplasm
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
Samples (54 total) of bladder tumor and corresponding normal bladder mucosa were analyzed for the methylation and expression levels of six Wnt-antagonist genes (sFRP-1, sFRP-2, sFRP-4, and sFRP-5, Wif-1, and Dkk-3).
|
16609023 |
2006 |
Bladder Neoplasm
|
0.050 |
AlteredExpression
|
disease |
BEFREE |
WIF1, a component of the Wnt pathway, is down-regulated in prostate, breast, lung, and bladder cancer.
|
14517837 |
2003 |
Bladder Neoplasm
|
0.050 |
Biomarker
|
disease |
BEFREE |
These observations suggest a mechanism for transformation of bladder epithelium on loss of WIF1 function and provide new targets such as SKP2 for intervention in WIF1-deficient bladder cancer.
|
19174556 |
2009 |
Bladder Neoplasm
|
0.050 |
PosttranslationalModification
|
disease |
LHGDN |
Samples (54 total) of bladder tumor and corresponding normal bladder mucosa were analyzed for the methylation and expression levels of six Wnt-antagonist genes (sFRP-1, sFRP-2, sFRP-4, and sFRP-5, Wif-1, and Dkk-3).
|
16609023 |
2006 |
Bladder Neoplasm
|
0.050 |
PosttranslationalModification
|
disease |
LHGDN |
Nuclear accumulation of beta-catenin was significantly more frequent in bladder tumor than in bladder mucosa and inversely correlated with Wif-1 expression.
|
16428476 |
2006 |
Bladder Neoplasm
|
0.050 |
Biomarker
|
disease |
BEFREE |
The increased methylation levels of WIF1 DNA CpG could be a potential biomarker for bladder cancer.
|
31322264 |
2019 |
bone destruction
|
0.010 |
Biomarker
|
disease |
BEFREE |
Wnt inhibitory factor 1 deficiency uncouples cartilage and bone destruction in tumor necrosis factor α-mediated experimental arthritis.
|
23784913 |
2013 |
Brain Neoplasms
|
0.010 |
AlteredExpression
|
group |
BEFREE |
WIF1 expression inhibited cell migration in vitro and in an orthotopic brain tumor model, in accordance with the known regulatory function of the WNT/Ca(2+) pathway on migration and invasion.
|
25772239 |
2016 |
Breast Cancer, Familial
|
0.010 |
PosttranslationalModification
|
disease |
BEFREE |
Silencing of tumor suppressor genes RASSF1A, SLIT2, and WIF1 by promoter hypermethylation in hereditary breast cancer.
|
22315090 |
2013 |
Breast Carcinoma
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
WIF1 and DKK3 promoter methylation were detected in 63.3% (95/150) and 61.3% (92/150) of breast carcinoma samples, respectively.
|
19570204 |
2009 |
Breast Carcinoma
|
0.020 |
PosttranslationalModification
|
disease |
BEFREE |
Our findings establish the WIF1 gene as a target for epigenetic silencing in breast cancer and provide a mechanistic link between the dysregulation of Wnt signaling and breast tumorigenesis.
|
16501252 |
2006 |
Cancer of Nasopharynx
|
0.300 |
Biomarker
|
disease |
CTD_human |
The tumor suppressor Wnt inhibitory factor 1 is frequently methylated in nasopharyngeal and esophageal carcinomas.
|
17384664 |
2007 |
Carcinogenesis
|
0.100 |
PosttranslationalModification
|
phenotype |
BEFREE |
Our findings establish the WIF1 gene as a target for epigenetic silencing in breast cancer and provide a mechanistic link between the dysregulation of Wnt signaling and breast tumorigenesis.
|
16501252 |
2006 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
WIF-1 gene inhibition and Wnt signal transduction pathway activation in NSCLC tumorigenesis.
|
28454231 |
2017 |
Carcinogenesis
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
Wnt inhibitory factor 1 decreases tumorigenesis and metastasis in osteosarcoma.
|
20197388 |
2010 |